Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 13/20 | 0.91 |
| ▸ | PDPK1 | O15530 | 3/20 | 0.91 |
| ▸ | PHLPP1 | O60346 | 3/20 | 0.91 |
| ▸ | ILK | Q13418 | 3/20 | 0.91 |
| ▸ | LMNA | P02545 | 3/20 | 0.72 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.65 |
| ▸ | TTPA | P49638 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | USP2 | O75604 | 1/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.62 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gamma-Tocopherol SCHEMBL14695405 | 1.00 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL120346 | 1.00 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL17874900 | 1.00 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL14580952 | 1.00 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL16430717 | 1.00 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL29373100 | 1.00 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL39640 | 1.00 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| SCHEMBL15441242 | 1.00 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL29620131 | 1.00 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL28686334 | 0.99 | AKT1 (0.89) | AKT1PDPK1PHLPP1ILKLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190192449-A1 | COMPOSITION AND USE THEREOF | BAYBUTT RICHARD (US) | 2019-06-27 | — | — | US | claimed |
| US-20260014120-A1 | COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF SALTS OF CARNOSINE AND CARNITINE | NeuviDerm LLC (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250381240-A1 | COMPOSITIONS AND METHODS FOR HAIR TREATMENT | NEUVIAN SKINCARE LLC (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250339545-A1 | ANTIOXIDANT COMPOSITIONS AND METHODS | LEUVIAN LLC (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250281563-A1 | COMPOSITIONS AND METHODS FOR HAIR TREATMENT | NEUVIAN IP HOLDINGS, LLC | 2025-09-11 | — | — | US | disclosed |
| US-12409204-B1 | Compositions and methods for hair treatment | NEUVIAN IP HOLDINGS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-12377156-B2 | Compositions and methods for treatment of wounds and inflammatory skin conditions | NEUVIAN IP HOLDINGS, LLC (US) | 2025-08-05 | — | — | US | disclosed |
| WO-2025090117-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF WOUNDS AND INFLAMMATORY SKIN CONDITIONS | LEUVIAN, LLC (US) | 2025-05-01 | — | — | WO | disclosed |
| US-20250127911-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF WOUNDS AND INFLAMMATORY SKIN CONDITIONS | NEUVIAN IP HOLDINGS, LLC | 2025-04-24 | — | — | US | disclosed |
| US-20230338309-A1 | COMPOSITIONS AND METHODS FOR TOPICAL TREATMENT OF VASCULAR CONDITIONS | JSS RESEARCH, LLC | 2023-10-26 | — | — | US | disclosed |
| US-20140221674-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | EDISON PHARMACEUTICALS, INC. (US) | 2014-08-07 | — | — | US | disclosed |
| US-8575369-B2 | Process for the production of alpha-tocotrienol and derivatives | EDISON PHARMACEUTICALS, INC. (US) | 2013-11-05 | — | — | US | disclosed |
| US-8575369-B2 | Process for the production of alpha-tocotrienol and derivatives | EDISON PHARMACEUTICALS, INC. (US) | 2013-11-05 | — | — | US | disclosed |
| US-20120130093-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | PTC THERAPEUTICS, INC. | 2012-05-24 | — | — | US | disclosed |
| US-20120130093-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | PTC THERAPEUTICS, INC. | 2012-05-24 | — | — | US | disclosed |
| US-8106223-B2 | Process for the production of alpha-tocotrienol and derivatives | EDISON PHARMACEUTICALS, INC. (US) | 2012-01-31 | — | — | US | disclosed |
| US-8106223-B2 | Process for the production of alpha-tocotrienol and derivatives | EDISON PHARMACEUTICALS, INC. (US) | 2012-01-31 | — | — | US | disclosed |
| WO-2010051277-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | EDISON PHARMACEUTICALS, INC. (US) | 2010-05-06 | — | — | WO | disclosed |
| US-20100105930-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | PTC THERAPEUTICS, INC. | 2010-04-29 | — | — | US | disclosed |
| US-20100105930-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | PTC THERAPEUTICS, INC. | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12409204-B1 | Compositions and methods for hair treatment | AOC1, SOD3, OAT | AKT1 3895/4885PDPK1 3933/4885PHLPP1 2327/4885 |
| US-12377156-B2 | Compositions and methods for treatment of wounds and inflammatory skin conditions | SOD3, SOD1, CUTA | AKT1 2405/4885PDPK1 2892/4885PHLPP1 2346/4885 |
| US-20250127911-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF WOUNDS AND INFLAMMATORY SKIN CONDITIONS | SOD3, SOD1, CUTA | AKT1 2405/4885PDPK1 2892/4885PHLPP1 2346/4885 |
| US-20250339545-A1 | ANTIOXIDANT COMPOSITIONS AND METHODS | SOD1, SOD3, LPO | AKT1 2286/4885PDPK1 2212/4885PHLPP1 2558/4885 |
| US-20140221674-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | TTPA, LCAT, PCTP | AKT1 4031/4885PDPK1 1773/4885PHLPP1 4780/4885 |
| US-20120130093-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | TTPA, LCAT, PCTP | AKT1 4031/4885PDPK1 1773/4885PHLPP1 4780/4885 |
| US-20250281563-A1 | COMPOSITIONS AND METHODS FOR HAIR TREATMENT | AOC1, SOD3, OAT | AKT1 3895/4885PDPK1 3933/4885PHLPP1 2327/4885 |
| US-20190192449-A1 | COMPOSITION AND USE THEREOF | RXRG, RARG, TTPA | AKT1 3762/4885PDPK1 4376/4885PHLPP1 4209/4885 |
| US-20100105930-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | TTPA, LCAT, PCTP | AKT1 4031/4885PDPK1 1773/4885PHLPP1 4780/4885 |
| US-20260014120-A1 | COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF SALTS OF CARNOSINE AND CARNITINE | CRAT, CCR10, SLC25A20 | AKT1 2074/4885PDPK1 2489/4885PHLPP1 2030/4885 |
| US-20250381240-A1 | COMPOSITIONS AND METHODS FOR HAIR TREATMENT | AOC1, SOD3, OAT | AKT1 3895/4885PDPK1 3933/4885PHLPP1 2327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.